SAMHSA updates guidance on MOUD and harm reduction

The Substance Abuse and Mental Health Services Administration (SAMHSA) issued two Dear Colleague letters — one warning against the use of medications for opioid use disorder without accompanying support services, and one outlining the administration’s curtailed list of allowable harm reduction services.